APVO · Aptevo Therapeutics Inc.
$2.94
-0.46 (-13.53%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“When considered in aggregate, these factors raise substantial doubt about our ability to continue as a going concern for the one-year period from the date of issuance of these financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$5.30M
Shares
1.80M
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
Model estimate
Expected Aug 14 short interest
as of Aug 14
82,597
-5.7% vs reported
Short Squeeze Score
49/100
Short interest 4.9% of shares — P73
Days to cover 4.5 — P64
Price vs VWAP -33.9% — P6
Short-volume trend -8.1% — P22
Short interest change -36.2% — P9
Worst FTD 3.28% of shares — P97
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
| 2026-07-31 | 87,627 | 137,249 | -49,622 | 4.53 |
| 2026-07-15 | 137,249 | 79,436 | +57,813 | 1.00 |
| 2026-06-30 | 79,436 | 80,080 | -644 | 3.41 |
| 2026-06-15 | 80,080 | 80,160 | -80 | 2.17 |
| 2026-05-29 | 80,160 | 87,845 | -7,685 | 2.68 |
| 2026-05-15 | 87,845 | 92,205 | -4,360 | 1.49 |
| 2026-04-30 | 92,205 | 104,241 | -12,036 | 5.09 |
| 2026-04-15 | 104,241 | 133,103 | -28,862 | 3.80 |
| 2026-03-31 | 133,103 | 112,000 | +21,103 | 2.48 |
| 2026-03-13 | 112,000 | 116,763 | -4,763 | 1.00 |
| 2026-02-27 | 116,763 | 133,525 | -16,762 | 5.59 |
| 2026-02-13 | 133,525 | 152,186 | -18,661 | 2.68 |
| 2026-01-30 | 152,186 | 219,920 | -67,734 | 2.09 |
| 2026-01-15 | 219,920 | 139,996 | +79,924 | 1.00 |
| 2025-12-31 | 139,996 | 1,033,317 | -893,321 | 1.03 |
| 2025-12-15 | 57,407 | 21,723 | +35,683 | 1.00 |
| 2025-11-28 | 21,723 | 43,315 | -21,591 | 1.00 |
| 2025-11-14 | 43,315 | 27,847 | +15,468 | 1.07 |
| 2025-10-31 | 27,847 | 49,963 | -22,117 | 1.00 |
| 2025-10-15 | 49,963 | 77,373 | -27,410 | 1.00 |
| 2025-09-30 | 77,373 | 2,441 | +74,932 | 1.00 |
| 2025-09-15 | 2,441 | 5,678 | -3,237 | 1.00 |
| 2025-08-29 | 5,678 | 2,873 | +2,805 | 1.00 |
Showing 1–23 of 23 settlements
Key facts
CIK
1671584
CUSIP
03835L702
13F (30d)
10 filings
10 filers
Visit website
Investor relations